Alejandro Pironti
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Endocrinology top 5%
- Escherichia coli research studies
- Enterobacteriaceae and Cronobacter Research
Papers in
-
- HIV/AIDS drug development and treatment 13
- Antimicrobial Resistance in Staphylococcus 8
- Tuberculosis Research and Epidemiology 2
-
- Antibiotic Resistance in Bacteria 7
- Co-authors
- James E. Kirby (1 shared paper)Thea Brennan-Krohn (1 shared paper)Abigail L. Manson (3 shared papers)Ashlee M. Earl (3 shared papers)Deborah Tan Hung (2 shared papers)Christoph M. Ernst (2 shared papers)Carlos A. Rodríguez-Osorio (1 shared paper)Maura E. Benson (1 shared paper)
- Journals
- mBio (4 papers)eLife (3 papers)Nature Medicine (2 papers)Journal of Clinical Virology (2 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Alejandro Pironti
43 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 84
- Molecular Medicine 297
- Endocrinology 84
- Infectious Diseases 213
- Clinical Biochemistry 46
- Virology 35
Countries citing papers authored by Alejandro Pironti
This map shows the geographic impact of Alejandro Pironti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Pironti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Pironti more than expected).
Fields of papers citing papers by Alejandro Pironti
This network shows the impact of papers produced by Alejandro Pironti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Pironti. The network helps show where Alejandro Pironti may publish in the future.
Co-authors
The 25 scholars most cited alongside Alejandro Pironti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 230 | |
| 2 | 2022 | 173 | |
| 3 | 2019 | 104 | |
| 4 | 2018 | 91 | |
| 5 | 2023 | 50 | |
| 6 | 2023 | 49 | |
| 7 | 2012 | 33 | |
| 8 | 2018 | 31 | |
| 9 | 2013 | 30 | |
| 10 | 2022 | 29 | |
| 11 | 2011 | 25 | |
| 12 | 2015 | 25 | |
| 13 | 2023 | 25 | |
| 14 | 2017 | 20 | |
| 15 | 2021 | 20 | |
| 16 | 2023 | 18 | |
| 17 | 2018 | 13 | |
| 18 | 2023 | 13 | |
| 19 | Role of routine small intestinal biopsy in adult patient with irritable bowel syndrome-like symptoms. | 2010 | 12 |
| 20 | 2022 | 12 |
About Alejandro Pironti
Alejandro Pironti is a scholar working on Infectious Diseases, Molecular Medicine, Virology, Molecular Biology and Applied Microbiology and Biotechnology, having authored 45 papers that have together received 1.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (13 papers), Antimicrobial Resistance in Staphylococcus (8 papers), Antibiotic Resistance in Bacteria (7 papers), Gut microbiota and health (5 papers), HIV Research and Treatment (4 papers), Genomics and Phylogenetic Studies (3 papers), Bacterial biofilms and quorum sensing (2 papers) and Tuberculosis Research and Epidemiology (2 papers). The work is most often cited by research in Molecular Medicine (297 citations), Endocrinology (84 citations), Infectious Diseases (213 citations), Clinical Biochemistry (46 citations) and Virology (35 citations). Alejandro Pironti has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include James E. Kirby, Thea Brennan-Krohn, Abigail L. Manson, Ashlee M. Earl, Deborah Tan Hung, Christoph M. Ernst, Carlos A. Rodríguez-Osorio, Maura E. Benson, Anne E. Clatworthy and Li Li. Their work appears in journals such as mBio, eLife, Nature Medicine, Journal of Clinical Virology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.